company background image
EKF

EKF Diagnostics Holdings AIM:EKF Stock Report

Last Price

UK£0.35

Market Cap

UK£159.2m

7D

1.2%

1Y

-54.8%

Updated

24 May, 2022

Data

Company Financials +
EKF fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends2/6

EKF Stock Overview

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally.

EKF Diagnostics Holdings Competitors

Price History & Performance

Summary of all time highs, changes and price drops for EKF Diagnostics Holdings
Historical stock prices
Current Share PriceUK£0.35
52 Week HighUK£0.87
52 Week LowUK£0.33
Beta1.01
1 Month Change-6.67%
3 Month Change-31.37%
1 Year Change-54.78%
3 Year Change5.10%
5 Year Change70.73%
Change since IPO-15.66%

Recent News & Updates

Apr 14
Some EKF Diagnostics Holdings plc (LON:EKF) Analysts Just Made A Major Cut To Next Year's Estimates

Some EKF Diagnostics Holdings plc (LON:EKF) Analysts Just Made A Major Cut To Next Year's Estimates

Today is shaping up negative for EKF Diagnostics Holdings plc ( LON:EKF ) shareholders, with the analysts delivering a...

Shareholder Returns

EKFGB Medical EquipmentGB Market
7D1.2%-0.6%-0.4%
1Y-54.8%-16.9%-3.0%

Return vs Industry: EKF underperformed the UK Medical Equipment industry which returned -17.2% over the past year.

Return vs Market: EKF underperformed the UK Market which returned -2.7% over the past year.

Price Volatility

Is EKF's price volatile compared to industry and market?
EKF volatility
EKF Average Weekly Movement8.8%
Medical Equipment Industry Average Movement6.2%
Market Average Movement6.0%
10% most volatile stocks in GB Market11.6%
10% least volatile stocks in GB Market3.1%

Stable Share Price: EKF is more volatile than 75% of UK stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: EKF's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of UK stocks.

About the Company

FoundedEmployeesCEOWebsite
1990386Mike Salterhttps://www.ekfdiagnostics.com

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. The company also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab A1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test A1c for the monitoring and management of diabetes; and STAT-Site M Beta-hydroxybutyrate analyzer.

EKF Diagnostics Holdings Fundamentals Summary

How do EKF Diagnostics Holdings's earnings and revenue compare to its market cap?
EKF fundamental statistics
Market CapUK£159.23m
Earnings (TTM)UK£15.85m
Revenue (TTM)UK£81.84m

10.0x

P/E Ratio

1.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
EKF income statement (TTM)
RevenueUK£81.84m
Cost of RevenueUK£42.47m
Gross ProfitUK£39.37m
Other ExpensesUK£23.52m
EarningsUK£15.85m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.035
Gross Margin48.10%
Net Profit Margin19.37%
Debt/Equity Ratio0.7%

How did EKF perform over the long term?

See historical performance and comparison

Dividends

3.4%

Current Dividend Yield

35%

Payout Ratio

Valuation

Is EKF Diagnostics Holdings undervalued compared to its fair value and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


>50%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: EKF (£0.35) is trading below our estimate of fair value (£0.91)

Significantly Below Fair Value: EKF is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: EKF is good value based on its Price-To-Earnings Ratio (10x) compared to the UK Medical Equipment industry average (26.9x).

PE vs Market: EKF is good value based on its Price-To-Earnings Ratio (10x) compared to the UK market (15.4x).


Price to Earnings Growth Ratio

PEG Ratio: EKF's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: EKF is good value based on its Price-To-Book Ratio (1.7x) compared to the GB Medical Equipment industry average (2.8x).


Future Growth

How is EKF Diagnostics Holdings forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


-9.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: EKF's earnings are forecast to decline over the next 3 years (-9.9% per year).

Earnings vs Market: EKF's earnings are forecast to decline over the next 3 years (-9.9% per year).

High Growth Earnings: EKF's earnings are forecast to decline over the next 3 years.

Revenue vs Market: EKF's revenue (0.06% per year) is forecast to grow slower than the UK market (4% per year).

High Growth Revenue: EKF's revenue (0.06% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: EKF's Return on Equity is forecast to be low in 3 years time (11.1%).


Past Performance

How has EKF Diagnostics Holdings performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


39.7%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: EKF has high quality earnings.

Growing Profit Margin: EKF's current net profit margins (19.4%) are higher than last year (17%).


Past Earnings Growth Analysis

Earnings Trend: EKF has become profitable over the past 5 years, growing earnings by 39.7% per year.

Accelerating Growth: EKF's earnings growth over the past year (42.6%) exceeds its 5-year average (39.7% per year).

Earnings vs Industry: EKF earnings growth over the past year (42.6%) exceeded the Medical Equipment industry 22.3%.


Return on Equity

High ROE: EKF's Return on Equity (17.1%) is considered low.


Financial Health

How is EKF Diagnostics Holdings's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: EKF's short term assets (£47.6M) exceed its short term liabilities (£13.7M).

Long Term Liabilities: EKF's short term assets (£47.6M) exceed its long term liabilities (£6.7M).


Debt to Equity History and Analysis

Debt Level: EKF has more cash than its total debt.

Reducing Debt: EKF's debt to equity ratio has reduced from 8.6% to 0.7% over the past 5 years.

Debt Coverage: EKF's debt is well covered by operating cash flow (1471%).

Interest Coverage: EKF's interest payments on its debt are well covered by EBIT (949.7x coverage).


Balance Sheet


Dividend

What is EKF Diagnostics Holdings's current dividend yield, its reliability and sustainability?

Dividend Score

3/6

Dividend Score 3/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


3.43%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: EKF's dividend (3.43%) is higher than the bottom 25% of dividend payers in the UK market (1.78%).

High Dividend: EKF's dividend (3.43%) is low compared to the top 25% of dividend payers in the UK market (4.85%).


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, EKF has been paying a dividend for less than 10 years.

Growing Dividend: EKF's dividend payments have increased, but the company has only paid a dividend for 2 years.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (34.6%), EKF's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its high cash payout ratio (119%), EKF's dividend payments are not well covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

3.4yrs

Average management tenure


CEO

Mike Salter (60 yo)

0.58

Tenure

UK£262,000

Compensation

Mr. David Michael Salter, also known as Mike, has been Executive Director at EKF Diagnostics Holdings plc since August 2021 and its Chief Executive Officer since October 1, 2021. He was Head of US operatio...


CEO Compensation Analysis

Compensation vs Market: Mike's total compensation ($USD328.01K) is below average for companies of similar size in the UK market ($USD663.05K).

Compensation vs Earnings: Insufficient data to compare Mike's compensation with company performance.


Leadership Team

Experienced Management: EKF's management team is considered experienced (3.4 years average tenure).


Board Members

Experienced Board: EKF's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

EKF Diagnostics Holdings plc's employee growth, exchange listings and data sources


Key Information

  • Name: EKF Diagnostics Holdings plc
  • Ticker: EKF
  • Exchange: AIM
  • Founded: 1990
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: UK£159.226m
  • Shares outstanding: 454.93m
  • Website: https://www.ekfdiagnostics.com

Number of Employees


Location

  • EKF Diagnostics Holdings plc
  • Avon House
  • 19 Stanwell Road
  • Cardiff
  • South Glamorgan
  • CF64 2EZ
  • United Kingdom

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/24 00:00
End of Day Share Price2022/05/24 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.